Neurodegenerative Diseases

Neurodegenerative diseases, such as Alzheimer's, Parkinson's, and ALS, are characterized by progressive neuronal loss due to complex mechanisms including oxidative stress, mitochondrial dysfunction, and protein aggregation. Understanding these mechanisms paves the way for personalized approaches in treatment, tailoring interventions to individual genetic and molecular profiles. Recent advances in treatment include novel therapies targeting specific pathways involved in neurodegeneration, such as gene editing and stem cell therapy. Enhanced diagnostic tools and biomarker discoveries are also improving early detection and management, allowing for more effective and individualized care strategies to mitigate the impact of these debilitating disorders.

    Related Conference of Neurodegenerative Diseases

    March 09-10, 2026

    7th Annual Congress on Psychiatry

    Singapore City, Singapore
    March 23-24, 2026

    4th World Congress on Psychiatry

    Tokyo, Japan
    April 13-14, 2026

    8th International Congress on Mental Health

    Tokyo, Japan
    April 20-21, 2026

    33rd World Psychiatrists and Psychologists Meet

    Rome, Italy
    May 27-28, 2026

    8th European Autism Congress

    Paris, France
    June 01-02, 2026

    11th International Conference on Addiction Therapy

    Zurich, Switzerland
    September 23-24, 2026

    6th Annual Congress on Mental Health

    Dubai, UAE
    October 19-20, 2026

    6thAnnual Congress on Mental Health & Psychiatry

    Paris, France

    Neurodegenerative Diseases Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in